OpenAlex
PricingAboutJobs
Log inGet started
Work

Sitagliptin as a Novel Treatment Agent for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus

HTML

Year: 2011
Type: article
Study design: Clinical Trial
Source: Hepatogastroenterology
DOI: 10.5754/hge11263
Authors: Tomoyuki Iwasaki, Masato Yoneda, Masahiko Inamori, Jun Shirakawa, Takuma Higurashi, Shin Maeda, Yasuo Terauchi, Atsushi Nakajima
Institution: Yokohama City University
Language: English

Topic: Liver Disease Diagnosis and Treatment
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Keywords: sitagliptin, non-alcoholic fatty liver disease, type 2 diabetes, DPP-4 inhibitors, glycemic control, HbA1c, liver enzymes, metabolic syndrome
SDG: Good health and well-being

Open Access status: closed

Funder: Japan Society for the Promotion of Science
Award: Development of noninvasive diagnosis by using IGF and IGFBP-1 for predicting nonalcoholic steatohepatitis(NASH).
OpenAlex ID: W2026049223
FWCI: 5.526
Cites:
Cited by: 132
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security